المؤلفون: Årdal C; Christine Årdal, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. She was a co-lead on the DRIVE-AB project. Jostein Johnsen was a senior adviser on public health and pharmaceutical/vaccine supply at the Norwegian Institute of Public Health. Karianne Johansen, M.S.M., Ph.D., is a senior adviser at the Norwegian Institute of Public Health, specializing in innovation, regulatory challenges, and health technology assessment within vaccines and antibiotic resistance., Johnsen J; Christine Årdal, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. She was a co-lead on the DRIVE-AB project. Jostein Johnsen was a senior adviser on public health and pharmaceutical/vaccine supply at the Norwegian Institute of Public Health. Karianne Johansen, M.S.M., Ph.D., is a senior adviser at the Norwegian Institute of Public Health, specializing in innovation, regulatory challenges, and health technology assessment within vaccines and antibiotic resistance., Johansen K; Christine Årdal, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. She was a co-lead on the DRIVE-AB project. Jostein Johnsen was a senior adviser on public health and pharmaceutical/vaccine supply at the Norwegian Institute of Public Health. Karianne Johansen, M.S.M., Ph.D., is a senior adviser at the Norwegian Institute of Public Health, specializing in innovation, regulatory challenges, and health technology assessment within vaccines and antibiotic resistance.

المصدر: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2018 Jun; Vol. 46 (1_suppl), pp. 43-49.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium: Internet ISSN: 1748-720X (Electronic) Linking ISSN: 10731105 NLM ISO Abbreviation: J Law Med Ethics

مواضيع طبية MeSH: Anti-Bacterial Agents/*supply & distribution , Drug Discovery/*economics, Drug Resistance, Microbial ; Health Services Accessibility ; Humans ; Norway ; Pilot Projects ; Technology Assessment, Biomedical

المؤلفون: Storehagen L; Live Storehagen, M.Pharm., M.Phil., is an advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Friha Aftab, M.D., is working at the Oslo University Hospital, Norway. She wrote her dr.med. thesis on controlled medicines and antibiotic stewardship. Christine Årdal, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Miloje Savic, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. John-Arne Røttingen, M.D., Ph.D., M.Sc., M.P.A., is the Chief Executive of the Research Council of Norway and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health., Aftab F; Live Storehagen, M.Pharm., M.Phil., is an advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Friha Aftab, M.D., is working at the Oslo University Hospital, Norway. She wrote her dr.med. thesis on controlled medicines and antibiotic stewardship. Christine Årdal, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Miloje Savic, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. John-Arne Røttingen, M.D., Ph.D., M.Sc., M.P.A., is the Chief Executive of the Research Council of Norway and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health., Årdal C; Live Storehagen, M.Pharm., M.Phil., is an advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Friha Aftab, M.D., is working at the Oslo University Hospital, Norway. She wrote her dr.med. thesis on controlled medicines and antibiotic stewardship. Christine Årdal, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Miloje Savic, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. John-Arne Røttingen, M.D., Ph.D., M.Sc., M.P.A., is the Chief Executive of the Research Council of Norway and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health., Savic M; Live Storehagen, M.Pharm., M.Phil., is an advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Friha Aftab, M.D., is working at the Oslo University Hospital, Norway. She wrote her dr.med. thesis on controlled medicines and antibiotic stewardship. Christine Årdal, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Miloje Savic, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. John-Arne Røttingen, M.D., Ph.D., M.Sc., M.P.A., is the Chief Executive of the Research Council of Norway and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health., Røttingen JA; Live Storehagen, M.Pharm., M.Phil., is an advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Friha Aftab, M.D., is working at the Oslo University Hospital, Norway. She wrote her dr.med. thesis on controlled medicines and antibiotic stewardship. Christine Årdal, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. Miloje Savic, Ph.D., is a senior advisor on global health and antimicrobial resistance for the Norwegian Institute of Public Health (NIPH) in Oslo, Norway. John-Arne Røttingen, M.D., Ph.D., M.Sc., M.P.A., is the Chief Executive of the Research Council of Norway and Adjunct Professor at the Department of Global Health and Population, Harvard T.H. Chan School of Public Health.

المصدر: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2018 Jun; Vol. 46 (1_suppl), pp. 81-94.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium: Internet ISSN: 1748-720X (Electronic) Linking ISSN: 10731105 NLM ISO Abbreviation: J Law Med Ethics

مواضيع طبية MeSH: Anti-Bacterial Agents* , Drug and Narcotic Control*, Drug Prescriptions ; Drug Resistance, Microbial ; Humans ; Inappropriate Prescribing/prevention & control

المؤلفون: Baraldi E; Enrico Baraldi, Ph.D., is Professor of Industrial Engineering and Management at Uppsala University. His research focuses on innovation studies, business strategy, industrial marketing and purchasing, and commercialization of science. Olof Lindahl, Ph.D., is an Assistant Professor of International Business at Uppsala University. His research focuses on multinational corporations, managing innovation, and strategy. Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. David Findlay, M.B.A., was a Global Commercial Director for anti-infectives at GSK and has a B.Sc. in Experimental Psychology from Reading University and an M.B.A. specializing in international business strategy from the University of Bradford's Management Centre. Christine Årdal, Ph.D., is a Senior Advisor at the Norwegian Institute of Public Health, co-lead for the DRIVE-AB research project, and co-lead on the European Union's Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. Her research focuses are within antibiotic and neglected disease policy, particularly in regards to innovation and access., Lindahl O; Enrico Baraldi, Ph.D., is Professor of Industrial Engineering and Management at Uppsala University. His research focuses on innovation studies, business strategy, industrial marketing and purchasing, and commercialization of science. Olof Lindahl, Ph.D., is an Assistant Professor of International Business at Uppsala University. His research focuses on multinational corporations, managing innovation, and strategy. Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. David Findlay, M.B.A., was a Global Commercial Director for anti-infectives at GSK and has a B.Sc. in Experimental Psychology from Reading University and an M.B.A. specializing in international business strategy from the University of Bradford's Management Centre. Christine Årdal, Ph.D., is a Senior Advisor at the Norwegian Institute of Public Health, co-lead for the DRIVE-AB research project, and co-lead on the European Union's Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. Her research focuses are within antibiotic and neglected disease policy, particularly in regards to innovation and access., Savic M; Enrico Baraldi, Ph.D., is Professor of Industrial Engineering and Management at Uppsala University. His research focuses on innovation studies, business strategy, industrial marketing and purchasing, and commercialization of science. Olof Lindahl, Ph.D., is an Assistant Professor of International Business at Uppsala University. His research focuses on multinational corporations, managing innovation, and strategy. Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. David Findlay, M.B.A., was a Global Commercial Director for anti-infectives at GSK and has a B.Sc. in Experimental Psychology from Reading University and an M.B.A. specializing in international business strategy from the University of Bradford's Management Centre. Christine Årdal, Ph.D., is a Senior Advisor at the Norwegian Institute of Public Health, co-lead for the DRIVE-AB research project, and co-lead on the European Union's Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. Her research focuses are within antibiotic and neglected disease policy, particularly in regards to innovation and access., Findlay D; Enrico Baraldi, Ph.D., is Professor of Industrial Engineering and Management at Uppsala University. His research focuses on innovation studies, business strategy, industrial marketing and purchasing, and commercialization of science. Olof Lindahl, Ph.D., is an Assistant Professor of International Business at Uppsala University. His research focuses on multinational corporations, managing innovation, and strategy. Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. David Findlay, M.B.A., was a Global Commercial Director for anti-infectives at GSK and has a B.Sc. in Experimental Psychology from Reading University and an M.B.A. specializing in international business strategy from the University of Bradford's Management Centre. Christine Årdal, Ph.D., is a Senior Advisor at the Norwegian Institute of Public Health, co-lead for the DRIVE-AB research project, and co-lead on the European Union's Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. Her research focuses are within antibiotic and neglected disease policy, particularly in regards to innovation and access., Årdal C; Enrico Baraldi, Ph.D., is Professor of Industrial Engineering and Management at Uppsala University. His research focuses on innovation studies, business strategy, industrial marketing and purchasing, and commercialization of science. Olof Lindahl, Ph.D., is an Assistant Professor of International Business at Uppsala University. His research focuses on multinational corporations, managing innovation, and strategy. Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. David Findlay, M.B.A., was a Global Commercial Director for anti-infectives at GSK and has a B.Sc. in Experimental Psychology from Reading University and an M.B.A. specializing in international business strategy from the University of Bradford's Management Centre. Christine Årdal, Ph.D., is a Senior Advisor at the Norwegian Institute of Public Health, co-lead for the DRIVE-AB research project, and co-lead on the European Union's Joint Action on Antimicrobial Resistance and Healthcare-Associated Infections. Her research focuses are within antibiotic and neglected disease policy, particularly in regards to innovation and access.

المصدر: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2018 Jun; Vol. 46 (1_suppl), pp. 25-31.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium: Internet ISSN: 1748-720X (Electronic) Linking ISSN: 10731105 NLM ISO Abbreviation: J Law Med Ethics

مواضيع طبية MeSH: Anti-Bacterial Agents* , Drug Discovery*, Drug Development/*organization & administration, Drug Resistance, Microbial ; Financing, Organized ; Humans ; Motivation ; Research Support as Topic

المؤلفون: Savic M; Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. Christine Årdal, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health., Årdal C; Miloje Savic, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health. Christine Årdal, Ph.D., is a senior adviser on public health and antimicrobial resistance at the Norwegian Institute of Public Health.

المصدر: The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics [J Law Med Ethics] 2018 Jun; Vol. 46 (1_suppl), pp. 9-24.

نوع المنشور: Journal Article; Research Support, Non-U.S. Gov't

بيانات الدورية: Publisher: Cambridge University Press Country of Publication: England NLM ID: 9315583 Publication Model: Print Cited Medium: Internet ISSN: 1748-720X (Electronic) Linking ISSN: 10731105 NLM ISO Abbreviation: J Law Med Ethics

مواضيع طبية MeSH: Anti-Bacterial Agents* , Biomedical Research* , Drug Discovery* , Financing, Organized*, Drug Resistance, Microbial ; Humans ; Motivation ; Public-Private Sector Partnerships ; Research Support as Topic